What is the treatment for non-bullous impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Non-Bullous Impetigo

For non-bullous impetigo with limited lesions, topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment, but switch to oral antibiotics (dicloxacillin 250 mg four times daily or cephalexin 250-500 mg four times daily for adults) if lesions are extensive, involve multiple sites, or fail to respond after 3-5 days. 1, 2

Initial Assessment and Treatment Selection

When to Use Topical Therapy

  • Topical mupirocin 2% ointment applied three times daily for 5-7 days is the preferred first-line treatment for localized impetigo 1, 2, 3
  • Retapamulin applied twice daily for 5 days is an alternative topical option 1
  • Topical therapy is preferred for limited disease due to fewer systemic side effects 2
  • Do not use bacitracin or neomycin—they are considerably less effective and should not be used for impetigo treatment 4

When to Switch to Oral Antibiotics

You must use oral antibiotics in these situations:

  • Extensive disease or numerous lesions 1, 4
  • Lesions on the face, eyelid, or mouth 4
  • No response to topical therapy after 3-5 days 4, 2
  • Outbreaks affecting multiple people (to decrease transmission) 1
  • Systemic symptoms present 4
  • When topical therapy is impractical 2

Oral Antibiotic Regimens

For Presumed Methicillin-Susceptible S. aureus (MSSA)

Most S. aureus isolates from impetigo are methicillin-susceptible, making these your first-line oral options: 1

  • Dicloxacillin 250 mg four times daily for adults (7-10 days) 1, 4, 2
  • Cephalexin 250-500 mg four times daily for adults (7-10 days) 1, 4, 2

For Suspected or Confirmed MRSA

If MRSA is suspected or confirmed, use one of these agents: 1

  • Clindamycin 300-450 mg three times daily for adults 1, 4, 2
  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily for adults 1, 4
  • Doxycycline (alternative option) 1

If Cultures Yield Streptococci Alone

  • Oral penicillin is the recommended agent when only streptococci are isolated 1
  • Critical pitfall: Penicillin alone is NOT effective for impetigo when S. aureus is present, as it lacks adequate staphylococcal coverage 4, 2

Culture Guidance

Gram stain and culture of pus or exudates are recommended to identify whether S. aureus and/or β-hemolytic Streptococcus is the cause, but treatment without these studies is reasonable in typical cases 1

When Cultures Are Strongly Recommended:

  • Treatment failure 4, 2
  • MRSA is suspected 4, 2
  • Recurrent infections 4, 2

Duration of Therapy

  • Topical treatment: 5-7 days 1, 4, 2
  • Oral antibiotics: 7-10 days 1, 4, 2

Special Populations

Pediatric Patients

  • Dicloxacillin: 12 mg/kg/day in 4 divided doses 2
  • Avoid tetracyclines (doxycycline, minocycline) in children under 8 years 4, 2
  • Topical mupirocin has demonstrated 78% clinical efficacy in pediatric patients aged 2 months to 15 years 3

Pregnant Patients

  • Cephalexin is generally considered safe for pregnant patients 4, 2
  • Avoid tetracyclines in pregnant women 4, 2

Penicillin-Allergic Patients

  • Clindamycin is the preferred alternative for penicillin-allergic patients 4

Prevention of Spread

  • Keep lesions covered with clean, dry bandages 4, 2
  • Maintain good personal hygiene with regular handwashing 4
  • Avoid sharing personal items that contact the skin 4

Monitoring and Follow-Up

  • Re-evaluate if no improvement after 48-72 hours of therapy 2
  • Consider alternative diagnosis if presentation is atypical or not responding to appropriate therapy 2

Special Circumstances: Poststreptococcal Glomerulonephritis Outbreaks

Systemic antimicrobials should be used for infections during outbreaks of poststreptococcal glomerulonephritis to help eliminate nephritogenic strains of Streptococcus pyogenes from the community 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Impetigo on Hand Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.